Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
The human nasal mucosa is in osmotic equilibrium with isotonic body fluids at approximately 290300 mOsm/kg
The method of embodiment 55, wherein the composition comprises between about 0.01% to about 20% by weight of the poloxamer, about 0.01% to about 15% by weight of the poloxamer, about 0.01% to about 10% by weight of the poloxamer, about 0.01% to about 7% by weight of the poloxamer, about 0.01% to about 5% by weight of the poloxamer, about 0.01% to about 3% by weight of the poloxamer, about 0.01% to about 2% by weight of the poloxamer, or about 0.01% to about 1% by weight of the poloxamer
KEY FEATURES GHK-Cu lyophilised research-grade peptide 50mg per vial Independent HPLC-MS verified to 99.76% purity (CoA on public Lab Results portal) Single-batch fill, single-batch chromatogram no blending across lots Synthesised in accredited contract laboratories with full QA paper trail Crimp-sealed, tamper-evident research vial in unbranded outer packaging Dispatched from Australia on Auspost Express with insulated cold-pack option SPECIFICATIONS Product Name GHK-Cu Category Copper Peptides Grade Research grade laboratory use only Quantity 50mg per vial Form Lyophilised powder cake Purity 99.76% verified by HPLC-MS Appearance White to off-white lyophilised solid Storage 28 C lyophilised
This enhanced blood flow supports tissue regeneration and accelerates recovery time
US$ 25.96
US$ 21.15
US$ 29.46
US$ 27.08
US$ 22.88
